The Buccella Group worked with an international team of colleagues to identify a protein controlling magnesium as a therapeutic target for treating non-alcoholic fatty liver disease (NASH). The study was published in the Journal of Hepatology and was featured as an NYU Research Highlight. NYU Chemistry authors include graduate student Jessica Gruskos (currently at BMS) and undergraduate researcher Kevan Chu (currently at Weill Cornell grad school), as well as Professor Daniela Buccella.
Read the Journal of Hepatology article, entitled: "Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH"
Read the NYU Research Highlight, entitled: "Protein Controlling Magnesium Identified as Therapeutic Target for Non-alcoholic Fatty Liver Disease"